share_log

Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5

Alliance Global Partners Initiates Coverage On Fortress Biotech With Buy Rating, Announces Price Target of $5

Alliance Global Partners以買入評級啓動對豐澤生物技術的報道,宣佈目標股價爲5美元
Benzinga ·  03/19 08:20

Alliance Global Partners initiates coverage on Fortress Biotech (NASDAQ:FBIO) with a Buy rating and announces Price Target of $5.

Alliance Global Partners開始對豐澤生物科技(納斯達克股票代碼:FBIO)進行報道,評級爲買入,並宣佈目標股價爲5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論